Literature DB >> 18691557

Neuronal nicotinic acetylcholine receptors: from the genetic analysis to neurological diseases.

O K Steinlein1, D Bertrand.   

Abstract

Nicotinic acetylcholine receptors (nAChRs) are ligand-gated channels that mediate, in the peripheral nervous system, fast neurotransmission at the neuromuscular junction and in ganglia. Widely expressed in the central nervous system neuronal nAChRs are thought to contribute both to neurotransmission and modulation of neuronal activity. To date, eleven genes encoding for these receptors have been identified in the mammalian genome and their structure is well conserved throughout evolution. Progresses made in the field of genetics and the identification of a large number of small genetic variants such as single nucleotide polymorphisms raise new questions about the physiologic and pharmacologic consequences of such variations. The finding of associations between polymorphisms in the genes encoding for the neuronal nAChRs and neurological disorders such as schizophrenia and Alzheimer disease illustrate the importance of getting a better understanding of these receptors from the gene to function. In this work we present an overview over the progress that has been made in understanding the role of nAChR genes in monogenic disorders such as familial epilepsy, and review the latest knowledge about genetic variants of the nAChR genes and their relationship with common disorders and behavioural traits of complex etiology.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18691557     DOI: 10.1016/j.bcp.2008.07.012

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  20 in total

1.  Computational modeling study of human nicotinic acetylcholine receptor for developing new drugs in the treatment of alcoholism.

Authors:  Zeng-Jian Hu; Li Bai; Yousef Tizabi; William Southerland
Journal:  Interdiscip Sci       Date:  2009-11-14       Impact factor: 2.233

2.  Mutational analysis of CHRNB2, CHRNA2 and CHRNA4 genes in Chinese population with autosomal dominant nocturnal frontal lobe epilepsy.

Authors:  Zhihong Chen; Lingan Wang; Chun Wang; Qian Chen; Qiongxiang Zhai; Yuxiong Guo; Yuxin Zhang
Journal:  Int J Clin Exp Med       Date:  2015-06-15

3.  Understanding of nicotinic acetylcholine receptors.

Authors:  Jie Wu
Journal:  Acta Pharmacol Sin       Date:  2009-06       Impact factor: 6.150

Review 4.  Modeling and simulation of ion channels.

Authors:  Christopher Maffeo; Swati Bhattacharya; Jejoong Yoo; David Wells; Aleksei Aksimentiev
Journal:  Chem Rev       Date:  2012-10-04       Impact factor: 60.622

Review 5.  Heteromeric α7β2 Nicotinic Acetylcholine Receptors in the Brain.

Authors:  Jie Wu; Qiang Liu; Pei Tang; Jens D Mikkelsen; Jianxin Shen; Paul Whiteaker; Jerrel L Yakel
Journal:  Trends Pharmacol Sci       Date:  2016-05-11       Impact factor: 14.819

Review 6.  Using C. elegans to decipher the cellular and molecular mechanisms underlying neurodevelopmental disorders.

Authors:  Carlos Bessa; Patrícia Maciel; Ana João Rodrigues
Journal:  Mol Neurobiol       Date:  2013-03-14       Impact factor: 5.590

Review 7.  Nicotinic receptor channelopathies and epilepsy.

Authors:  Ortrud K Steinlein; Daniel Bertrand
Journal:  Pflugers Arch       Date:  2009-12-17       Impact factor: 3.657

8.  A signal peptide missense mutation associated with nicotine dependence alters α2*-nicotinic acetylcholine receptor function.

Authors:  Bhagirathi Dash; Ronald J Lukas; Ming D Li
Journal:  Neuropharmacology       Date:  2014-01-24       Impact factor: 5.250

Review 9.  CNV and nervous system diseases--what's new?

Authors:  W Gu; J R Lupski
Journal:  Cytogenet Genome Res       Date:  2009-03-11       Impact factor: 1.636

10.  Palmitoylation of nicotinic acetylcholine receptors.

Authors:  J K Alexander; A P Govind; R C Drisdel; M P Blanton; Y Vallejo; T T Lam; W N Green
Journal:  J Mol Neurosci       Date:  2009-08-20       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.